Recital 4, Regulation (EU) 2025/117

In forcesince 24 Jan 2025

Under Article 30(1) of Regulation (EU) 2021/2282, the Commission is to set up and maintain an IT platform consisting of, inter alia, a secure system for the exchange of information between the Coordination Group and its subgroups with health technology developers and experts participating in the joint work (‘the HTA IT platform’). The health technology developers should therefore submit the requests for joint scientific consultations, the dossier of information, data, analyses and other evidence for joint scientific consultation on medical devices and in vitro diagnostic medical devices including the list of questions (‘the briefing package’) and any further data through the HTA IT platform. Those requests and dossiers should be presented using the templates set out by the Coordination Group pursuant to Article 21, points (a) and (b), of Regulation (EU) 2021/2282.